Zhengye Biotechnology Holding Limited Operating Lease, Right-of-Use Asset, Amortization Expense
Zhengye Biotechnology Holding Limited (ZYBT) reported Operating Lease, Right-of-Use Asset, Amortization Expense of CNY 72.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-04-28
CNY
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|
| 2025-12-31 | 72.00K CNY 20-F · filed 2026-04-28 |
USD
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|
| 2025-12-31 | $10.00K 20-F · filed 2026-04-28 |